Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
Effect of smoking on multiple sclerosis: a meta-analysis.
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
[Immunomodulation and neuroprotection in optic neuritis].
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Extended interval dosing of natalizumab in multiple sclerosis.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Optical Coherence Tomography in Multiple Sclerosis.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Pages